DRREDDY vs LT: Stock Comparison
Larsen & Toubro Ltd is the larger company by market capitalisation. Dr Reddys Laboratories Ltd shows a lower P/E, lower leverage and a higher net margin, while Larsen & Toubro Ltd shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
DRREDDY leads 5; LT leads 8 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | DRREDDY | LT |
|---|---|---|
| Sector | Healthcare | Construction |
| Industry | Pharmaceuticals | Civil Construction |
Price
| Metric | DRREDDY | LT |
|---|---|---|
| Live Price | ₹1,193.5 | ₹4,119 |
| Day Change | 0.29% | 0.71% |
| Volume | 15.7 L | 13.16 L |
| 52-Week High | ₹1,414.9 | ₹4,440 |
| 52-Week Low | ₹1,101 | ₹3,288.1 |
| Distance from 52W High | -15.65% | -7.23% |
Valuation
| Metric | DRREDDY | LT |
|---|---|---|
| Market Cap | ₹99,281 Cr | ₹5.66 L Cr |
| P/E Ratio | 30.85x | 34.13x |
| P/B Ratio | 2.62x | 5.18x |
| EPS | ₹39.7 | ₹120.74 |
| Book Value | ₹460.31 | ₹794.47 |
| Dividend Yield | 0.68% | 0.93% |
Growth
| Metric | DRREDDY | LT |
|---|---|---|
| Revenue Growth (TTM YoY) | -11.6% | 11.7% |
| EPS Growth (TTM YoY) | -86.2% | -34.5% |
| Qtr Sales Growth | -11.5% | 11.2% |
| Qtr Profit Growth | -86.1% | 2.11% |
Profitability & Leverage
| Metric | DRREDDY | LT |
|---|---|---|
| ROE | 11.2% | 15.9% |
| ROCE | 13% | 14.6% |
| Net Margin | 12.76% | 6.04% |
| Operating Margin | 19.2% | 12.4% |
| Debt to Equity | 0.2x | 1.15x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | DRREDDY | LT |
|---|---|---|
| Promoter Holding | 26.64%▲ 0.01 pp | — |
| FII Holding | 32.07%▼ 1.01 pp | 19.13%▲ 0.35 pp |
| DII Holding | 31.74%▲ 1.02 pp | 43.02%▼ 0.31 pp |
| Public Holding | 9.35%▲ 0.02 pp | 37.6%▼ 0.04 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Dr Reddys Laboratories Ltd and Larsen & Toubro Ltd.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.